483 Sun Pharmaceutical Industries Mar 2019

483 Sun Pharmaceutical Industries Mar 2019

Cheryl Clausen FDA, Angela Glenn FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Dadra, India facility and issued inspectional observations (via FDA 483) on 29 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Mar 2019
  • Location: Dadra, India
  • FEI: 3004561553
Add To Cart